AMANTADINE DOSAGE IN TREATMENT OF PARKINSON'S DISEASE
- 1 May 1970
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 295 (7657) , 1130-1133
- https://doi.org/10.1016/s0140-6736(70)91211-0
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Antiparkinsonian Drugs: Inhibition of Dopamine Uptake in the Corpus Striatum as a Possible Mechanism of ActionScience, 1969
- The toxicologic and pharmacologic properties of amantadine hydrochlorideToxicology and Applied Pharmacology, 1969
- EFFECTS OF L-DOPA IN PARKINSON'S DISEASEThe Lancet, 1969
- Amantadine in the Treatment of Parkinson's DiseaseJAMA, 1969
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- ARTANE® THERAPY FOR PARKINSONISMJAMA, 1949